Issuance of Stock Acquisition Rights for Directors and Employees
First written in FY2025. 1 of 2 entries say "Restated". Latest entry: FY2026.
- FY2026RestatedAnnual report
「Second Series Stock Acquisition Rights Number of stock acquisition rights (rights) 12,300 Class, description and number of shares underlying the stock acquisition rights (shares) Common shares 1,230,000 Exercise period for the stock acquisition rights 1 March 2027 to 9 February 2035」
The terms and exercise period for 31,900 stock acquisition rights covering 3.19 million shares for directors, employees and others remained unchanged as of the end of the fiscal year. - FY2025First statedAnnual report
「Second Series Stock Acquisition Rights Number of stock acquisition rights (rights) 12,300 Class, description and number of shares underlying the stock acquisition rights (shares) Common shares 1,230,000 Exercise period for the stock acquisition rights 1 March 2027 to 9 February 2035 Third Series Stock Acquisition Rights Number of stock acquisition rights (rights) 19,600 Class, description and number of shares underlying the stock acquisition rights (shares) Common shares 1,960,000 Exercise period for the stock acquisition rights 1 March 2027 to 9 February 2034」
For the stock acquisition rights resolved on 10 February 2025 and granted on 1 March, a total of 31,900 rights, representing a total of 3.19 million common shares, were granted to directors, officers of affiliates, employees and others. The Second Series also carries an exercise condition requiring the closing share price to be at least ¥110.